Clinical Trial

Impact of Mindfulness Intervention on Quality of Life in Patients With Drug-resistant Epilepsy.

Study acronym: EPIMEDIT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 8, 2024 (before its estimated January 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study evaluates a mindfulness intervention in patients with drug resistant epilepsy. Half of participants will follow a mindfulness programme, while the other half will follow a self management programme.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-10-11; most recent amendment 2024-05-07.
Status change: Not Yet Recruiting → Recruiting 2020-11-03
Trial Details
NCT Number NCT04126369
Lead Sponsor University Hospital, Grenoble
Conditions Drug Resistant Epilepsy
Enrollment 100 participants
Start Date 2020-01-20
Primary Completion 2026-01-20 (estimated)
Study Completion 2027-09-20 (estimated)
Updated on ClinicalTrials.gov 2024-05-08